Gain-of-function mutations in fibroblast growth factor receptor (FGFR) genes are known to cause a range of skeletal disorders ...

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

The role of salvage cystectomy after prior trimodality therapy. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This abstract does not include a full text ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...

Pancreatic cancer, one of the most aggressive and lethal types of cancer, continues to present significant challenges in both its detection and treatment. The lack of early detection tools, coupled ...

引言激素受体阳性（HR+）/人表皮生长因子受体 2 阴性（HER2-）乳腺癌是最常见的乳腺癌亚型，约占所有乳腺癌的 70%。近年来，细胞周期蛋白依赖性激酶 4/6（CDK4/6）抑制剂联合内分泌治疗已成为 HR+/HER2- 晚期乳腺癌的一线标准治疗 ...

编者按：2025年美国临床肿瘤学会泌尿男生殖系肿瘤分会（ASCO GU 2025）年会正在美国旧金山举行，这场全球瞩目的学术盛会汇聚了顶尖肿瘤学者，共同探索泌尿肿瘤领域的前沿突破与未来方向。在ASCO ...

GU ASCO annual meeting featured a session on the ABCs of antibody drug conjugates and a presentation by Dr. Di Maria Jiang discussing the targeting of bladder cancer with antibody drug conjugates. Dr.

BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...